Rehabilitation Strategies to Improve Outcomes For Patients With a Lower Extremity Fracture (RIFLE)

July 5, 2023 updated by: Brian W. Noehren
The purpose of this study is to evaluate speed high intensity interval training (HIIT) walking program following an orthopedic trauma.

Study Overview

Detailed Description

In HIIT an individual gives short bursts of high effort followed by a longer recovery period.

Increasingly, HIIT style training programs have been used in other clinical populations (heart conditions, kidney failure, severely obese) to yield improved health outcomes and have been shown to be safe and effective. However, this work has not been extended to the orthopedic trauma population. Initiating a treadmill HIIT program during recovery from a lower extremity fracture may prove pivotal to restoring functional abilities, improving strength, and optimizing patient outcomes.

As a starting point to investigate the speed HIIT walking program following an orthopedic trauma, the investigators will focus on femoral and tibial shaft fractures requiring surgical fixation. Subjects will be recruited at a follow-up visit and therefore will not have impaired consent capacity issues at that juncture based on their fracture-related injuries. Even though early postoperative weight bearing has been shown to be safe, there continues to be considerable divergence in recovery after these fractures. For instance, return to work rates for individuals with physical jobs has been reported to be as low as 14% within the first year, resulting in significant stress and financial challenges for the individual. Clearly, improved post-operative rehabilitation strategies are needed for this population.

Aim 1: Assess the feasibility and adherence of the speed HIIT walk program within subjects with a lower extremity fracture.

Primary Hypothesis: 70% of subjects approached about the study will consent and that 80% of subjects will complete the study.

Secondary hypothesis: 80% of subjects will complete all of the treatment sessions and find the treatment (both intervention and standard of care physical therapy) acceptable.

Aim 2: Determine the preliminary effects of the speed HIIT program as compared to the standard of care on patient reported outcomes, functional outcomes and return to work rates, in a pilot randomized control trial.

Primary Hypotheses: Participants in the speed HIIT intervention group will have a significantly higher PROMIS physical function scale as compared to standard of care group at a 6 month follow up.

Secondary hypotheses: Participants in the Speed HIIT intervention group will have higher return to work rates, usual and fastest gait speed, timed step-down test, and 6-minute walk test than the standard of care group at a 6 month follow up.

Tertiary hypothesis: The participants in the speed HIIT program will maintain higher physical function and return to work rates at a 12 month follow up as compared to the standard of care group

Aim 3: Quantify the differences in ground reaction forces, function, psychosocial responses, and patient reported outcomes that occur at the completion of the speed HIIT walk program as compared to the group receiving standard of care physical therapy.

Primary Hypotheses: Participants in the speed HIIT program will be significantly more symmetric in their peak ground reaction force metrics (impulse, loading rates, time, peak values), and have greater self reported physical function, functional outcomes and patient reported outcomes as compared to the standard of care group at the completion of the intervention (19 weeks post hospital discharge).

Secondary hypotheses: Participants completing the speed HIIT program will have greater pain self-efficacy and less fear of movement as compared to the standard of care at the completion of the intervention (19 weeks post hospital discharge) that is maintained at a 6 and 12 month follow up.

Tertiary hypothesis: The participants in the speed HIIT program will maintain higher symmetry in their peak ground reaction force metrics (impulse, loading rates, time, peak values) as compared to the standard of care group at a 6 month follow up.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Kentucky
      • Lexington, Kentucky, United States, 40506
        • Recruiting
        • University of Kentucky
    • Tennessee
      • Nashville, Tennessee, United States, 37203
        • Recruiting
        • Vanderbilt University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Ability to read and speak English
  • Acute orthopedic injury to the femoral or tibial shaft requiring surgical fixation with an intramedullary rod
  • Age 18-50 years of age

Exclusion Criteria:

  • History of chronic pain defined as pain lasting more than 3 months and bothersome at least half the days over the past 6 months that started before the fracture
  • Moderate or severe traumatic brain injury
  • Initial treatment requiring amputation
  • Not employed at the time of the accident at least 20 hours per week.
  • Spinal cord injury
  • History of schizophrenia, dementia or neurologic disorder with peripheral dysfunction
  • Non ambulatory or limited ability to walk without an assistive device prior to the fracture
  • Multiple trauma that prevents early weight bearing
  • Current Pregnancy
  • Unable to participate in or complete in-person follow-up visits or therapy sessions
  • In outpatient Physical Therapy at the start of the intervention
  • Use of an assistive device to walk for community ambulation at the 10-12 weeks post hospital discharge time point

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Standard of Care Physical Therapy Program
Standard of care will follow best practice. The subjects and their physical therapists will be provided with a standardized set of exercises and guidance on what to cover during skilled physical therapy visits.
Standard of care will follow best practice. The subjects and their physical therapists will be provided with a standardized set of exercises and guidance on what to cover during skilled physical therapy visits. As part of the study, all patients will receive the same exercise program. Exercises will include lower extremity strengthening, balance, and mobility exercises with the use of modalities as needed
Experimental: Standard of Care Physical Therapy Program with Speed Walking Intervention
Standard of care will follow best practice. The subjects and their physical therapists will be provided with a standardized set of exercises and guidance on what to cover during skilled physical therapy visits. Additionally, subjects will complete the speed walking intervention. Participants will perform at 2 minute warm up followed by 1 minute of walking at their fastest tolerable speed followed by 2 minutes of active recovery where they will walk at a speed of their choosing. The subjects will perform 4 cycles of this followed by a 2 minute cool down at the end.
Standard of care will follow best practice. The subjects and their physical therapists will be provided with a standardized set of exercises and guidance on what to cover during skilled physical therapy visits. As part of the study, all patients will receive the same exercise program. Exercises will include lower extremity strengthening, balance, and mobility exercises with the use of modalities as needed
The 4-6 week program will consist of a warm up of active stretching. Following the warm up, subjects will perform a 2 minute warm up followed by 1 minute of walking at their fastest comfortable speed followed by 2 minutes of active recovery where they will walk at a speed of their choosing for 4cycles and then a 2 minute cool down. The program will be performed 12 visits over 4-6 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported physical function
Time Frame: Up to 12 weeks
Patient Reported Outcomes Measurement Information System (PROMIS) Physical Function Questionnaire is a 53 question survey with a five point Likert scale ranging from 1 to 5 where a higher number indicates less physical function.
Up to 12 weeks
Self-reported physical function
Time Frame: Up to 19 weeks
Patient Reported Outcomes Measurement Information System (PROMIS) Physical Function Questionnaire is a 53 question survey with a five point Likert scale ranging from 1 to 5 where a higher number indicates less physical function.
Up to 19 weeks
Self-reported physical function
Time Frame: 6 months
Patient Reported Outcomes Measurement Information System (PROMIS) Physical Function Questionnaire is a 53 question survey with a five point Likert scale ranging from 1 to 5 where a higher number indicates less physical function.
6 months
Self-reported physical function
Time Frame: 12 months
Patient Reported Outcomes Measurement Information System (PROMIS) Physical Function Questionnaire is a 53 question survey with a five point Likert scale ranging from 1 to 5 where a higher number indicates less physical function.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
60-second step down test
Time Frame: Up to 12 weeks

Standing on an 4-inch box, participants will step down until the heel gently touches a scale placed on the ground and then return to full knee extension. As many repetitions as possible in 60 seconds will be recorded. Repetitions with over 10% of the body weight registered on the scale will not be counted toward the total number of repetitions completed. The test has previously been shown to have a high interrater reliability of 0.94 and was associated with a change in knee mechanics following an orthopedic surgery.

Interpretation: More successful repetitions indicate greater neuromuscular control and muscle strength in the lower extremity.

Up to 12 weeks
60-second step down test
Time Frame: Up to 19 weeks

Standing on an 4-inch box, participants will step down until the heel gently touches a scale placed on the ground and then return to full knee extension. As many repetitions as possible in 60 seconds will be recorded. Repetitions with over 10% of the body weight registered on the scale will not be counted toward the total number of repetitions completed. The test has previously been shown to have a high interrater reliability of 0.94 and was associated with a change in knee mechanics following an orthopedic surgery.

Interpretation: More successful repetitions indicate greater neuromuscular control and muscle strength in the lower extremity.

Up to 19 weeks
60-second step down test
Time Frame: 6 months.

Standing on an 4-inch box, participants will step down until the heel gently touches a scale placed on the ground and then return to full knee extension. As many repetitions as possible in 60 seconds will be recorded. Repetitions with over 10% of the body weight registered on the scale will not be counted toward the total number of repetitions completed. The test has previously been shown to have a high interrater reliability of 0.94 and was associated with a change in knee mechanics following an orthopedic surgery.

Interpretation: More successful repetitions indicate greater neuromuscular control and muscle strength in the lower extremity.

6 months.
Usual Gait Speed
Time Frame: Up to 12 weeks
Participant usual gait speed as measured over 2 trials of walking along a 20 meter walkway at their usual walking speed.
Up to 12 weeks
Usual Gait Speed
Time Frame: Up to 19 weeks
Participant usual gait speed as measured over 2 trials of walking along a 20 meter walkway at their usual walking speed.
Up to 19 weeks
Usual Gait Speed
Time Frame: 6 months
Participant usual gait speed as measured over 2 trials of walking along a 20 meter walkway at their usual walking speed.
6 months
Fastest Walking Speed
Time Frame: Up to 12 weeks
Participant usual gait speed as measured over 2 trials of walking along a 20 meter walkway at their fastest walking speed.
Up to 12 weeks
Fastest Walking Speed
Time Frame: Up to 19 weeks
Participant usual gait speed as measured over 2 trials of walking along a 20 meter walkway at their fastest walking speed.
Up to 19 weeks
Fastest Walking Speed
Time Frame: 6 months
Participant usual gait speed as measured over 2 trials of walking along a 20 meter walkway at their fastest walking speed.
6 months
Six-minute walk Test:
Time Frame: Up to 12 weeks
The participant will be provided with six minutes to walk as far as possible.
Up to 12 weeks
Six-minute walk Test:
Time Frame: Up to 19 weeks
The participant will be provided with six minutes to walk as far as possible.
Up to 19 weeks
Six-minute walk Test:
Time Frame: 6 months
The participant will be provided with six minutes to walk as far as possible.
6 months
Pain Assessment
Time Frame: Up to 12 weeks
Brief Pain Inventory (BPI) will be used to measure pain intensity. This is a four-item scale that measures current, worst, least, and average pain. Each of these four items are measured on a numeric scale from 0 to 10 with 0 being ''no pain'' and 10 being ''severe pain.''
Up to 12 weeks
Pain Assessment
Time Frame: Up to 19 weeks
Brief Pain Inventory (BPI) will be used to measure pain intensity. This is a four-item scale that measures current, worst, least, and average pain. Each of these four items are measured on a numeric scale from 0 to 10 with 0 being ''no pain'' and 10 being ''severe pain.''
Up to 19 weeks
Pain Assessment
Time Frame: 6 months
Brief Pain Inventory (BPI) will be used to measure pain intensity. This is a four-item scale that measures current, worst, least, and average pain. Each of these four items are measured on a numeric scale from 0 to 10 with 0 being ''no pain'' and 10 being ''severe pain.''
6 months
Pain Assessment
Time Frame: 12 months
Brief Pain Inventory (BPI) will be used to measure pain intensity. This is a four-item scale that measures current, worst, least, and average pain. Each of these four items are measured on a numeric scale from 0 to 10 with 0 being ''no pain'' and 10 being ''severe pain.''
12 months
Pain self-efficacy scale (PSEQ)
Time Frame: Up to 12 weeks

The Pain Self-Efficacy Questionnaire (PSEQ) is a 10-item questions and will be used measure an individual's beliefs about their ability to participate in social activity and accomplish their goals despite the presence of pain. PSEQ has demonstrated excellent internal consistency, test-retest reliability, and construct validity.

Interpretation: Greater self-efficacy (higher survey score) is related to reductions in disability, pain intensity, fear of movement and pain, and affective distress in patients with chronic pain.

Scale: 0-6 0 (not at all confident)

1 2 3 4 5 6 (completely confident)

Up to 12 weeks
Pain self-efficacy scale (PSEQ)
Time Frame: Up to 19 weeks

The Pain Self-Efficacy Questionnaire (PSEQ) is a 10-item questions and will be used measure an individual's beliefs about their ability to participate in social activity and accomplish their goals despite the presence of pain. PSEQ has demonstrated excellent internal consistency, test-retest reliability, and construct validity.

Interpretation: Greater self-efficacy (higher survey score) is related to reductions in disability, pain intensity, fear of movement and pain, and affective distress in patients with chronic pain.

Scale: 0-6 0 (not at all confident)

1 2 3 4 5 6 (completely confident)

Up to 19 weeks
Pain self-efficacy scale (PSEQ)
Time Frame: 6 months

The Pain Self-Efficacy Questionnaire (PSEQ) is a 10-item questions and will be used measure an individual's beliefs about their ability to participate in social activity and accomplish their goals despite the presence of pain. PSEQ has demonstrated excellent internal consistency, test-retest reliability, and construct validity.

Interpretation: Greater self-efficacy (higher survey score) is related to reductions in disability, pain intensity, fear of movement and pain, and affective distress in patients with chronic pain.

Scale: 0-6 0 (not at all confident)

1 2 3 4 5 6 (completely confident)

6 months
Pain self-efficacy scale (PSEQ)
Time Frame: 12 months

The Pain Self-Efficacy Questionnaire (PSEQ) is a 10-item questions and will be used measure an individual's beliefs about their ability to participate in social activity and accomplish their goals despite the presence of pain. PSEQ has demonstrated excellent internal consistency, test-retest reliability, and construct validity.

Interpretation: Greater self-efficacy (higher survey score) is related to reductions in disability, pain intensity, fear of movement and pain, and affective distress in patients with chronic pain.

Scale: 0-6 0 (not at all confident)

1 2 3 4 5 6 (completely confident)

12 months
Tampa scale of kinesiophobia (TSK)
Time Frame: Up to 12 weeks

The TSK is a 17-item questionnaire and will be administered to record fear of movement (kinesiophobia).

Interpretation: Higher survey scores indicates greater kinesiophobia in people with chronic pain.

Scale: (0-3) 0, Strongly disagree

  1. Disagree
  2. Agree
  3. Strongly agree
Up to 12 weeks
Tampa scale of kinesiophobia (TSK)
Time Frame: Up to 19 weeks

The TSK is a 17-item questionnaire and will be administered to record fear of movement (kinesiophobia).

Interpretation: Higher survey scores indicates greater kinesiophobia in people with chronic pain.

Scale: (0-3) 0, Strongly disagree

  1. Disagree
  2. Agree
  3. Strongly agree
Up to 19 weeks
Tampa scale of kinesiophobia (TSK)
Time Frame: 6 months

The TSK is a 17-item questionnaire and will be administered to record fear of movement (kinesiophobia).

Interpretation: Higher survey scores indicates greater kinesiophobia in people with chronic pain.

Scale: (0-3) 0, Strongly disagree

  1. Disagree
  2. Agree
  3. Strongly agree
6 months
Tampa scale of kinesiophobia (TSK)
Time Frame: 12 months

The TSK is a 17-item questionnaire and will be administered to record fear of movement (kinesiophobia).

Interpretation: Higher survey scores indicates greater kinesiophobia in people with chronic pain.

Scale: (0-3) 0, Strongly disagree

  1. Disagree
  2. Agree
  3. Strongly agree
12 months
Return to Work Status: Hours Worked
Time Frame: Up to 12 weeks
Work Productivity and Activity Impairment Questionnaire (WPAI) part 1 includes three questions about the number of hours worked in the last seven days.
Up to 12 weeks
Return to Work Status: Hours Worked
Time Frame: Up to 19 weeks
Work Productivity and Activity Impairment Questionnaire (WPAI) part 1 includes three questions about the number of hours worked in the last seven days.
Up to 19 weeks
Return to Work Status: Hours Worked
Time Frame: 6 months
Work Productivity and Activity Impairment Questionnaire (WPAI) part 1 includes three questions about the number of hours worked in the last seven days.
6 months
Return to Work Status: Hours Worked
Time Frame: 12 months
Work Productivity and Activity Impairment Questionnaire (WPAI) part 1 includes three questions about the number of hours worked in the last seven days.
12 months
Return to Work Status: Ability to Work
Time Frame: Up to 12 weeks
Work Productivity and Activity Impairment Questionnaire (WPAI) part 2 includes 2 questions with a 10 point scale where a lower number indicates a greater ability to work with no health problems.
Up to 12 weeks
Return to Work Status: Ability to Work
Time Frame: Up to 19 weeks
Work Productivity and Activity Impairment Questionnaire (WPAI) part 2 includes 2 questions with a 10 point scale where a lower number indicates a greater ability to work with no health problems.
Up to 19 weeks
Return to Work Status: Ability to Work
Time Frame: 6 months
Work Productivity and Activity Impairment Questionnaire (WPAI) part 2 includes 2 questions with a 10 point scale where a lower number indicates a greater ability to work with no health problems.
6 months
Return to Work Status: Ability to Work
Time Frame: 12 months
Work Productivity and Activity Impairment Questionnaire (WPAI) part 2 includes 2 questions with a 10 point scale where a lower number indicates a greater ability to work with no health problems.
12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Loading of the lower extremity
Time Frame: Up to 12 weeks
The ground reaction forces of the injured and non injured limb will be evaluated over the course of recovery to assess when loading between limbs becomes symmetric.
Up to 12 weeks
Loading of the lower extremity
Time Frame: Up to 19 weeks
The ground reaction forces of the injured and non injured limb will be evaluated over the course of recovery to assess when loading between limbs becomes symmetric.
Up to 19 weeks
Loading of the lower extremity
Time Frame: 6 months
The ground reaction forces of the injured and non injured limb will be evaluated over the course of recovery to assess when loading between limbs becomes symmetric.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brian Noehren, Ph.D., University of Kentucky

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 3, 2022

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

July 1, 2025

Study Registration Dates

First Submitted

November 29, 2021

First Submitted That Met QC Criteria

March 1, 2022

First Posted (Actual)

March 10, 2022

Study Record Updates

Last Update Posted (Actual)

July 6, 2023

Last Update Submitted That Met QC Criteria

July 5, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 65286
  • CDMRP-CDMRP-OR200133-A (Other Grant/Funding Number: Department of Defense)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Femoral Fracture

Clinical Trials on Standard of Care Physical Therapy Program

3
Subscribe